Recro Pharma
-
Exton-Based Recro Pharma’s Acquisition of Competitor a ‘Transformative Transaction’
Exton-based Recro Pharma has acquired its West Coast competitor, Irisys of San Diego, in a cash and stock deal valued at roughly $50 million, writes…
-
Veteran of Life Sciences Industry Replaces Founder of Malvern-Based Recro Pharma as CEO
Malvern-based Recro Pharma has named David Enloe its new president and CEO, writes John George for the Philadelphia Business Journal. Enloe replaces the company’s founder…
-
Malvern-Based Recro Pharma Sees Its Stock Plummet 34 Percent
Malvern-based Recro Pharma saw its stock plunge by more than 34 percent after the Food and Drug Administration rejected its new drug application for a…
-
FDA Rejects Malvern-Based Recro Pharma’s Application for Non-Opioid Pain Med
Recro Pharma’s stock took a major hit after the FDA rejected a new drug application for the Malvern company’s non-opioid pain medication, writes John George…
-
Malvern’s Recro Pharma Secures Nine-Figure Line of Credit
Malvern’s Recro Pharma has secured a line of credit worth $100 million from funds managed by Athyrium Capital Management, writes John George for the Philadelphia…
-
Malvern’s Recro Pharma Buys Non-Opioid Pain Treatments from Ivy League College
Recro Pharma is injecting some new prospects into its effort to alleviate surgical patients’ pain without the use of addictive opioids. The Malvern pharmaceutical company…
-
DNB Financial, Malvern’s Recro Pharma Added to Membership of Russell 3000 Index
DNB Financial Corporation, the parent of DNB First, and Malvern’s Recro Pharma, a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other…
-
Malvern’s Recro Pharma to Use Stock Proceeds on Potential Commercial Launch
Malvern’s Recro Pharma is already preparing for the potential commercial launch of its highly anticipated new drug with a $35.9 million public stock offering, writes…
-
Test Results on Non-Opioid Pain Med Bode Well for Malvern’s Recro Pharma
Recro Pharma’s latest drug test felt more like a shot of adrenaline than a sigh of relief when patients noted they were well aware of…
-
Don’t Start Your Startup without the Ideas x Innovation Network
The Ideas x Innovation Network (i2n) is a program within the Chester County Economic Development Council (CCEDC). The mission of i2n is to support emerging growth businesses…
-
Malvern’s Recro Pharma Looking to Raise $15 Million from Public Stock Offering
Malvern’s Recro Pharma is looking to raise $15 million through a public stock offering. Most of the funds are earmarked for ongoing late stage testing…
-
Chester County Daily News Business Briefs
VISTA Today Daily News Business Briefs are concise stories that bring you up to date with what’s going on around Chester County. UTC and Lockheed…
-
Chester County Business Daily News Briefs
Chester County business daily news briefs review yesterday’s business stories important to Chester County and beyond. Vanguard Group Sides With duPont’s Management, Fends Off Proxy…
-
Chester County Daily News Business Briefs
Chester County Daily News Business Briefs are short summaries and links to important Chester County’s business stories not included in VISTA Today’s daily news stream.…
-
Malvern’s Recro Pharma Prepping To Inject Second Pain Product Into Market
The promise of bringing pain relief to patients right out of surgery without using narcotics is another step closer to reality for a Malvern specialty…
-
Recro Pharma is on Track for Success
Recro Pharma Inc. (NASDAQ:REPH) released its fourth quarter and full year financial results for the period ending December 31, 2014 last month. The clinical stage pharmaceutical…
-
Recro Pharma, Inc. To Purchase Drug Manufacturing Facility In Georgia
Recro Pharma, Inc., a specialty pharmaceutical firm with offices in Malvern and Ireland, is purchasing a Georgia manufacturing facility from Alkermes PLC and global rights…
-
IPO Lock-Up Expiration Could Reveal Insiders’ Opinion Of Recro Pharma Of Malvern
Major shareholders and leaders inside a Malvern non-opioid pain therapeutics pharmaceutical company may show their hand concerning the firm’s future, now that Recro Pharma’s initial public…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
